Icu Medical (ICUI) Equity Income (2025 - 2026)
Icu Medical's (ICUI) quarterly Equity Income came in at $3.0 million in Q2 2026, up 6.2% on a YoY basis from $2.8 million in Q2 2025, and up 596.38% quarter-over-quarter from -$607000.0 in Q1 2026.
Powered by 
Analysis
Icu Medical (ICUI) Equity Income (2025 - 2026) Analysis & Trends
Icu Medical (ICUI) has reported Equity Income for 2 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Equity Income rose 6.2% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2026 stood at -$1.6 million (down 157.1% YoY), and the FY2025 full-year result was -$1.2 million, changed N/A from the prior year.
- Equity Income climbed to $3.0 million in Q2 2026 per ICUI's latest filing, from -$607000.0 in the prior quarter.
- Across five years, Equity Income topped out at $3.0 million in Q2 2026 and bottomed at -$2.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | - |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | - |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 2.23 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | - |
| 10 | Icu Medical | 3.82 Bn | 3.52 Bn | 235.05 Mn | 3.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.01 Mn |
| Mar 31, 2026 | -607,000.00 |
| Dec 31, 2025 | -2.49 Mn |
| Sep 30, 2025 | -1.54 Mn |
| Jun 30, 2025 | 2.84 Mn |